Time To Abolish High-Deductible Health Plans
A draft copy of the form proposed for use to apply for low-cost insurance from Medicaid Tuesday Mar. ... More 12, 2013. (AP Photo/J. David Ake)
Over the past decade and a half, the American healthcare system has undergone a silent revolution. I'm not referring to the Affordable Care Act, but instead to a separate paradigm shift in how Americans pay for their healthcare—they increasingly find themselves in insurance plans that carry high out-of-pocket expenses, meaning their coverage doesn't leave them well covered. Almost half of Americans younger than 65 are currently enrolled in high deductible health plans, required to pay for the first $1,000, $2,000, or even $5,000 of their health care expenses before their insurance kicks in. Euphemistically referred to as Consumer-Directed Health Plans, these high out-of-pocket programs are in theory supposed to incentivize people to scrutinize the cost and quality of their medical care, thus bringing pressure on providers to lower the price and/or raise the quality of their services.
This theory isn't borne out in practice. As a matter of practice and policy, we need to stop burdening people with the expense of necessary care.
As recently as a decade ago, less than 15% of Americans were enrolled in high-deductible health plans. Since then, American employers have turned to such plans to hold down the costs of the benefits they offer their employees. High-deductible health plans hold down employer expenses by shifting costs to employees. First, employers save money because the first $5,000 of each employee's healthcare expenses come out of those employees' pockets. Second, high-deductible health plans dissuade employees from receiving medical care. That saves employers money by lowering overall healthcare expenditures.
Both of these ways of saving money harm Americans. The shift of expenses from employer to employee is a huge financial burden on low- and middle-income Americans, for whom an unexpected $5,000 expense creates financial distress. High-deductible health plans put many people one illness away from missing their next mortgage payment.
High-deductible health plans frequently force people to decide whether to seek medical care. When facing high out-of-pocket expenses, people often avoid necessary medical care. They stop taking important medications or wait out troubling symptoms that require urgent intervention.
Consider what happens when people with diabetes get forced into high-deductible health plans by their employers. When they begin experiencing complications from their diabetes—perhaps early vision problems or symptoms suggesting the onset of heart disease—they hold off on receiving tests to evaluate those symptoms. People with high-deductible plans receive less testing than those with more generous coverage. That might save money in the short run. But what about later, when they experience retinal bleeding or clogged coronary arteries?
The turn towards high-deductible health plans has harmed Americans financially and medically. The federal government should disincentivize employers from pushing people into such plans by scaling back tax breaks for employers that provide only high-deductible plans to their employees.
Americans deserve insurance plans that cover them for what counts.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Times
38 minutes ago
- New York Times
People With Severe Diabetes Are Cured in Small Trial of New Drug
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need much lower doses. The experimental treatment, called zimislecel and made by Vertex Pharmaceuticals of Boston, involves stem cells that scientists prodded to turn into pancreatic islet cells, which regulate blood glucose levels. The new islet cells were infused and reached the pancreas, where they took up residence. The study was presented Friday evening at the annual meeting of the American Diabetes Association and published online by The New England Journal of Medicine. 'It's trailblazing work,' said Dr. Mark Anderson, professor and director of the diabetes center at the University of California in San Francisco. 'Being free of insulin is life changing,' added Dr. Anderson, who was not involved in the study. Vertex, like other drug companies, declined to announce the treatment's cost before the Food and Drug Administration approves it. The treatment, said Vertex spokeswoman Dee Smith, could potentially help all patients with type 1 diabetes, although they would need to weigh the risks against the benefits of possibly not needing insulin. Want all of The Times? Subscribe.
Associated Press
39 minutes ago
- Associated Press
NthJEN Announces the Launch of Revolutionary Smart Bed Technology to Prevent Bedsores and Patient Falls
06/20/2025, Overland Park, Kansas // PRODIGY: Feature Story // After nearly a decade of development, testing, and clinical feedback, NthJEN LLC announces the launch of its breakthrough multi-sensor smart bed technology into the healthcare market. Designed to monitor immobility, alert clinicians of risk, and help prevent injuries, the solution stands at the intersection of compassion, precision, and innovation. Founder and CEO Naveen Gogumalla calls it 'a just-in-time, technology-based solution for one of the most overlooked problems in healthcare.' NthJEN's smart bed system, powered by a thin, pressure-sensitive membrane layered over any standard bed, uses over a thousand sensors to continuously map the patient's pressure distribution and activity. Unlike traditional methods that rely on visual checks or outdated alarms, the system detects early signs of immobility or unsafe patterns that can lead to pressure ulcers or dangerous falls. It can even detect if a patient has gotten out of bed and failed to return within a safe timeframe, alerting staff in real-time. 'It's not just about alarms, it's about precision alerts that matter,' says Gogumalla. 'We have designed this system to reduce alarm fatigue by only alerting caregivers when necessary. If the patient is out of bed too long or has not moved in a high-risk position, that's when the system speaks up.' The journey to market began in 2017, when Gogumalla, whose background spans IT and healthcare, was approached by a wound care nurse desperate for a real solution. 'She said everyone was trying to help us with these wounds, but no one was solving the core issue,' he recalls. Motivated by that challenge, and deeply affected by the untimely passing of his sister due to a cardiac event, Gogumalla redirected his efforts to build something that could truly make a difference. 'I kept thinking, how can we use technology to keep people safe? That's what drove this,' he says. What emerged was a durable medical device that could be prescribed by physicians, used in homes or care facilities, and integrated into existing hospital infrastructure. The product is durable, waterproof, and reusable. It straps securely to the bed, reads pressure changes through advanced sensors, and communicates data to clinicians and caregivers via a web-based dashboard. In the future, NthJEN aims to consolidate even more clinical monitoring into the device, vitals, telemetry, and ambient sensors, all in one discreet system. 'One of the core advantages is remote access,' says Gogumalla. 'Family members can receive email alerts or log in to view the bed status. In an age where loved ones are spread across cities or countries, this level of connection provides peace of mind.' Over five years of testing have proven the product's resilience in both clinical and home environments. The system's data logging capabilities can even aid litigation defense by documenting caregiver responses to alarms. According to Gogumalla, the solution helps not just the patient, but the entire ecosystem of care. 'This makes the caregiver more efficient. You don't need to walk in and check unless the alert tells you something's wrong. That changes everything,' he states. The market demand is clear. In the U.S. alone, pressure ulcers and falls account for over $50 billion in treatment and liability costs annually. With the smart bed's ability to detect inactivity or absence before harm occurs, NthJEN offers prevention, not just response. And while some competitors use in-room cameras or rudimentary pressure sensors, NthJEN stands apart. 'We are not trying to map wounds. We are trying to prevent them,' Gogumalla clarifies. 'And we don't believe in turning bedrooms into surveillance zones. This system respects patient dignity while still improving care.' Gogumalla and his team are already working with experienced physical therapists, home care networks, and hospitals to bring the solution into more hands. 'Our vision goes beyond the bed,' he adds. 'We are working toward a future where the hospital room is less cluttered, more integrated, and remotely accessible. Imagine a doctor standing on a beach and checking your vitals remotely from the same system.' For Gogumalla, though, the focus remains grounded. 'This is not about me,' he says. 'It's about solving a real problem and getting it into the hands of people who need it: nurses, patients, caregivers, families. That's who we built it for.' Media Contact Name: Naveen Gogumalla Email: [email protected] The information provided in this article is for educational and informational purposes only and is not intended as medical advice. It is not a substitute for professional medical diagnosis, treatment, or care. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this article. Source published by Submit Press Release >> NthJEN Announces the Launch of Revolutionary Smart Bed Technology to Prevent Bedsores and Patient Falls
Associated Press
39 minutes ago
- Associated Press
Ibogaine by David Dardashti Forges Strategic Partnership with Psychedelic University to Cultivate Next-Generation Leaders in Psychedelic Healthcare
MIAMI, FL - June 20, 2025 - Ibogaine by David Dardashti, a pioneering leader in ibogaine-assisted therapy and led by visionary David Dardashti, today announced a groundbreaking collaboration with a Psychedelic University. This strategic partnership aims to establish robust internship opportunities for students passionate about contributing to the rapidly evolving psychedelic field, with initial networking prospects to be explored at the highly anticipated Psychedelic Conference 2025. The initiative is further amplified by the recent opening of Ibogaine by David Dardashti's second state-of-the-art treatment facility, significantly expanding the scope for student involvement. This innovative alliance is designed to bridge the gap between academic learning and practical application, providing students with invaluable hands-on experience in a clinical setting dedicated to transformative healing. The expansion into a second facility dramatically increases Ibogaine by David Dardashti's capacity, creating a diverse array of potential roles for aspiring professionals. 'We are incredibly excited to partner with Psychedelic University to nurture the next generation of leaders in psychedelic medicine,' said David Dardashti, founder of Ibogaine by David Dardashti. 'The opening of our second clinic is not just about expanding our treatment capabilities; it's about building a robust ecosystem where ambitious students can gain real-world experience and help accelerate the growth and acceptance of ibogaine therapy. We believe this collaboration will foster innovation and ethical practices crucial for the future of this field.' The internship program will offer multifaceted opportunities for students from various disciplines. Beyond direct clinical exposure, students can expect to engage in critical areas such as: Meetings will be held in the months following a patient's treatment, creating a unique longitudinal learning environment where interns can observe the full spectrum of patient journeys and recovery. This comprehensive approach ensures that students gain a holistic understanding of patient care, from initial intake to long-term integration support. Representatives from both Ibogaine by David Dardashti and Psychedelic University will be actively engaging with students at the Psychedelic Conference 2025, providing a premier platform for aspiring interns to learn more about these opportunities and network with pioneers in the field. This direct interaction will allow students to present their aspirations and demonstrate their commitment to this burgeoning area of healthcare. The ultimate goal of Ibogaine by David Dardashti is to expand its new clinic with the support of ambitious, dedicated students who are eager to contribute to accelerating the growth and responsible application of ibogaine treatment. This partnership underscores a shared commitment to innovation, education, and the widespread, ethical integration of psychedelic therapies into mainstream healthcare. Media Contact Company Name: Ibogaine By David Dardashti Contact Person: Cole Barressi Email: Send Email Country: United States Website: Press Release Distributed by To view the original version on ABNewswire visit: Ibogaine by David Dardashti Forges Strategic Partnership with Psychedelic University to Cultivate Next-Generation Leaders in Psychedelic Healthcare
